Groowe / Newsroom / TYRA

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TYRA News

Tyra Biosciences, Inc. Common Stock

Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights

prnewswire.com Nov 5, 2025 10:06 PM

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

prnewswire.com Aug 21, 2025 2:46 PM